Company intelligence / Profile preview

ExpressTec

Junction City, Kansas, United States
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

ExpressTec is a biopharmaceutical company specializing in high-yield, plant-based recombinant protein production. Utilizing its proprietary rice-based expression system, the company manufactures proteins, enzymes, and vaccines that are animal-free and cost-effective. The technology, originally developed by Ventria Bioscience, enables the production of complex proteins like lactoferrin and lysozyme for use in human health, nutrition, and cell culture media. ExpressTec operates a cGMP-compliant manufacturing facility in Kansas and provides contract manufacturing services to the broader biotech industry. The company's platform offers significant advantages in scalability and safety compared to traditional mammalian or microbial expression systems.

Therapeutic areas
ImmunologyInfectious DiseasesGastroenterology
Modalities
Recombinant proteinVaccineMonoclonal antibodyPeptides
Industry
Biotech
02

Partnerships

Bill & Melinda Gates Foundation

Beyond the preview

Go deeper on ExpressTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExpressTec.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call